Drug · DIN 02258455
PHL-RISPERIDONE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 9, 2006; first marketed August 9, 2006.
- Drug Identification Number (DIN)
- 02258455
- Company (DIN owner)
- Pharmel Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 1.0 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 27, 2006: NOC 8177Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named PHL-RISPERIDONE
- DIN 02258439 · Cancelled Post Market
- DIN 02258447 · Cancelled Post Market
- DIN 02258463 · Cancelled Post Market
- DIN 02258471 · Cancelled Post Market
- DIN 02258498 · Cancelled Post Market